nodes	percent_of_prediction	percent_of_DWPC	metapath
Floxuridine—stomach cancer—colon cancer	0.335	1	CtDrD
Floxuridine—TYMS—colon cancer	0.256	1	CbGaD
Floxuridine—TYMP—Capecitabine—colon cancer	0.131	0.382	CbGbCtD
Floxuridine—TYMP—Fluorouracil—colon cancer	0.0776	0.227	CbGbCtD
Floxuridine—TYMS—Capecitabine—colon cancer	0.0697	0.204	CbGbCtD
Floxuridine—TYMS—Fluorouracil—colon cancer	0.0413	0.121	CbGbCtD
Floxuridine—TYMS—Methotrexate—colon cancer	0.0228	0.0666	CbGbCtD
Floxuridine—Biliary fibrosis—Fluorouracil—colon cancer	0.008	0.185	CcSEcCtD
Floxuridine—Onychomadesis—Fluorouracil—colon cancer	0.00332	0.077	CcSEcCtD
Floxuridine—TYMP—endothelium—colon cancer	0.00209	0.167	CbGeAlD
Floxuridine—TYMP—blood vessel—colon cancer	0.00193	0.154	CbGeAlD
Floxuridine—Nail changes—Fluorouracil—colon cancer	0.00191	0.0442	CcSEcCtD
Floxuridine—Cerebellar syndrome—Fluorouracil—colon cancer	0.00138	0.032	CcSEcCtD
Floxuridine—Nail changes—Capecitabine—colon cancer	0.00133	0.0309	CcSEcCtD
Floxuridine—Arterial thrombosis—Irinotecan—colon cancer	0.00107	0.0249	CcSEcCtD
Floxuridine—Nail changes—Methotrexate—colon cancer	0.000992	0.023	CcSEcCtD
Floxuridine—TYMP—smooth muscle tissue—colon cancer	0.000905	0.0723	CbGeAlD
Floxuridine—Ischaemia—Irinotecan—colon cancer	0.000792	0.0184	CcSEcCtD
Floxuridine—TYMS—smooth muscle tissue—colon cancer	0.000777	0.062	CbGeAlD
Floxuridine—TYMP—Pyrimidine metabolism—TYMS—colon cancer	0.000747	0.0871	CbGpPWpGaD
Floxuridine—TYMP—lymphoid tissue—colon cancer	0.000724	0.0578	CbGeAlD
Floxuridine—TYMP—digestive system—colon cancer	0.000715	0.0571	CbGeAlD
Floxuridine—Trifluridine—TYMS—colon cancer	0.000705	0.862	CrCbGaD
Floxuridine—TYMP—bone marrow—colon cancer	0.000659	0.0526	CbGeAlD
Floxuridine—Duodenitis—Capecitabine—colon cancer	0.000658	0.0153	CcSEcCtD
Floxuridine—TYMP—vagina—colon cancer	0.000631	0.0504	CbGeAlD
Floxuridine—TYMS—lymphoid tissue—colon cancer	0.000621	0.0496	CbGeAlD
Floxuridine—TYMS—digestive system—colon cancer	0.000613	0.049	CbGeAlD
Floxuridine—TYMS—Vinorelbine—Vincristine—colon cancer	0.000601	0.593	CbGdCrCtD
Floxuridine—TYMP—Fluoropyrimidine Activity—TYMS—colon cancer	0.000579	0.0675	CbGpPWpGaD
Floxuridine—Enteritis—Capecitabine—colon cancer	0.000566	0.0131	CcSEcCtD
Floxuridine—TYMS—bone marrow—colon cancer	0.000565	0.0451	CbGeAlD
Floxuridine—TYMS—vagina—colon cancer	0.000542	0.0432	CbGeAlD
Floxuridine—Arterial thrombosis—Methotrexate—colon cancer	0.000535	0.0124	CcSEcCtD
Floxuridine—TYMP—liver—colon cancer	0.000533	0.0425	CbGeAlD
Floxuridine—Lacrimation—Irinotecan—colon cancer	0.000491	0.0114	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—FGFR3—colon cancer	0.000487	0.0567	CbGpPWpGaD
Floxuridine—Lacrimation—Fluorouracil—colon cancer	0.000471	0.0109	CcSEcCtD
Floxuridine—TYMS—liver—colon cancer	0.000457	0.0365	CbGeAlD
Floxuridine—Embolism—Irinotecan—colon cancer	0.00045	0.0104	CcSEcCtD
Floxuridine—Nail disorder—Fluorouracil—colon cancer	0.000427	0.00989	CcSEcCtD
Floxuridine—Enteritis—Methotrexate—colon cancer	0.000421	0.00977	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—BRAF—colon cancer	0.00042	0.049	CbGpPWpGaD
Floxuridine—Nystagmus—Vincristine—colon cancer	0.000415	0.00963	CcSEcCtD
Floxuridine—TYMS—Vinblastine—Vincristine—colon cancer	0.000413	0.408	CbGdCrCtD
Floxuridine—TYMP—Bladder Cancer—CDH1—colon cancer	0.000411	0.0479	CbGpPWpGaD
Floxuridine—TYMP—lymph node—colon cancer	0.000408	0.0326	CbGeAlD
Floxuridine—Nystagmus—Fluorouracil—colon cancer	0.000387	0.00898	CcSEcCtD
Floxuridine—Myocardial ischaemia—Irinotecan—colon cancer	0.00036	0.00833	CcSEcCtD
Floxuridine—TYMS—lymph node—colon cancer	0.00035	0.028	CbGeAlD
Floxuridine—Myocardial ischaemia—Fluorouracil—colon cancer	0.000344	0.00798	CcSEcCtD
Floxuridine—Lacrimation increased—Irinotecan—colon cancer	0.000314	0.00727	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—CCND1—colon cancer	0.000307	0.0357	CbGpPWpGaD
Floxuridine—Embolism—Capecitabine—colon cancer	0.000301	0.00698	CcSEcCtD
Floxuridine—Lacrimation increased—Fluorouracil—colon cancer	0.0003	0.00696	CcSEcCtD
Floxuridine—Nail disorder—Capecitabine—colon cancer	0.000298	0.00691	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—CDKN1A—colon cancer	0.000297	0.0346	CbGpPWpGaD
Floxuridine—TYMP—Nucleotide metabolism—TYMS—colon cancer	0.000291	0.0339	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—MSH6—colon cancer	0.000286	0.0334	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—VEGFA—colon cancer	0.000267	0.0311	CbGpPWpGaD
Floxuridine—Photophobia—Fluorouracil—colon cancer	0.00026	0.00602	CcSEcCtD
Floxuridine—Rash maculo-papular—Fluorouracil—colon cancer	0.000252	0.00583	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—MYC—colon cancer	0.000246	0.0287	CbGpPWpGaD
Floxuridine—Thrombophlebitis—Irinotecan—colon cancer	0.000242	0.00562	CcSEcCtD
Floxuridine—Myocardial ischaemia—Capecitabine—colon cancer	0.000241	0.00558	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—EGFR—colon cancer	0.000241	0.028	CbGpPWpGaD
Floxuridine—Euphoric mood—Fluorouracil—colon cancer	0.000238	0.00551	CcSEcCtD
Floxuridine—Thrombophlebitis—Fluorouracil—colon cancer	0.000232	0.00538	CcSEcCtD
Floxuridine—Photosensitivity—Fluorouracil—colon cancer	0.000229	0.0053	CcSEcCtD
Floxuridine—Disorientation—Fluorouracil—colon cancer	0.000225	0.00521	CcSEcCtD
Floxuridine—Embolism—Methotrexate—colon cancer	0.000224	0.0052	CcSEcCtD
Floxuridine—Nail disorder—Methotrexate—colon cancer	0.000222	0.00515	CcSEcCtD
Floxuridine—Lacrimation increased—Capecitabine—colon cancer	0.00021	0.00487	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.000207	0.0241	CbGpPWpGaD
Floxuridine—Lethargy—Fluorouracil—colon cancer	0.000205	0.00475	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—TP53—colon cancer	0.000202	0.0235	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—TOP1—colon cancer	0.000198	0.0231	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—HRAS—colon cancer	0.000193	0.0225	CbGpPWpGaD
Floxuridine—TYMP—Fluoropyrimidine Activity—TP53—colon cancer	0.000192	0.0224	CbGpPWpGaD
Floxuridine—Cramp muscle—Irinotecan—colon cancer	0.000189	0.00438	CcSEcCtD
Floxuridine—Dry skin—Fluorouracil—colon cancer	0.000184	0.00427	CcSEcCtD
Floxuridine—Abscess—Methotrexate—colon cancer	0.000182	0.00422	CcSEcCtD
Floxuridine—Pancytopenia—Vincristine—colon cancer	0.000177	0.0041	CcSEcCtD
Floxuridine—Angina pectoris—Irinotecan—colon cancer	0.000177	0.00409	CcSEcCtD
Floxuridine—Photosensitivity reaction—Vincristine—colon cancer	0.00017	0.00394	CcSEcCtD
Floxuridine—Angina pectoris—Fluorouracil—colon cancer	0.000169	0.00392	CcSEcCtD
Floxuridine—TYMP—Metabolism—CA7—colon cancer	0.000168	0.0196	CbGpPWpGaD
Floxuridine—Pancytopenia—Fluorouracil—colon cancer	0.000165	0.00382	CcSEcCtD
Floxuridine—Thrombophlebitis—Capecitabine—colon cancer	0.000162	0.00376	CcSEcCtD
Floxuridine—Stomatitis—Vincristine—colon cancer	0.000162	0.00375	CcSEcCtD
Floxuridine—Photosensitivity—Capecitabine—colon cancer	0.00016	0.00371	CcSEcCtD
Floxuridine—Photosensitivity reaction—Fluorouracil—colon cancer	0.000159	0.00367	CcSEcCtD
Floxuridine—Gastroenteritis—Capecitabine—colon cancer	0.000158	0.00367	CcSEcCtD
Floxuridine—Stomatitis—Irinotecan—colon cancer	0.000158	0.00365	CcSEcCtD
Floxuridine—Glossitis—Methotrexate—colon cancer	0.000156	0.00362	CcSEcCtD
Floxuridine—Stomatitis—Fluorouracil—colon cancer	0.000151	0.0035	CcSEcCtD
Floxuridine—Epistaxis—Fluorouracil—colon cancer	0.000146	0.00339	CcSEcCtD
Floxuridine—Haemoglobin—Irinotecan—colon cancer	0.000146	0.00338	CcSEcCtD
Floxuridine—Haemorrhage—Irinotecan—colon cancer	0.000145	0.00336	CcSEcCtD
Floxuridine—Agranulocytosis—Fluorouracil—colon cancer	0.000144	0.00335	CcSEcCtD
Floxuridine—Lethargy—Capecitabine—colon cancer	0.000143	0.00332	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.000141	0.0164	CbGpPWpGaD
Floxuridine—Haemoglobin—Fluorouracil—colon cancer	0.00014	0.00324	CcSEcCtD
Floxuridine—Haemorrhage—Fluorouracil—colon cancer	0.000139	0.00322	CcSEcCtD
Floxuridine—Pharyngitis—Fluorouracil—colon cancer	0.000138	0.0032	CcSEcCtD
Floxuridine—Alopecia—Vincristine—colon cancer	0.000132	0.00305	CcSEcCtD
Floxuridine—Dry skin—Capecitabine—colon cancer	0.000129	0.00298	CcSEcCtD
Floxuridine—Alopecia—Irinotecan—colon cancer	0.000128	0.00297	CcSEcCtD
Floxuridine—Gastritis—Capecitabine—colon cancer	0.000124	0.00288	CcSEcCtD
Floxuridine—Alopecia—Fluorouracil—colon cancer	0.000123	0.00285	CcSEcCtD
Floxuridine—Muscle spasms—Irinotecan—colon cancer	0.000121	0.00282	CcSEcCtD
Floxuridine—Erythema—Fluorouracil—colon cancer	0.000121	0.0028	CcSEcCtD
Floxuridine—Thrombophlebitis—Methotrexate—colon cancer	0.000121	0.0028	CcSEcCtD
Floxuridine—Anaemia—Vincristine—colon cancer	0.00012	0.00278	CcSEcCtD
Floxuridine—Photosensitivity—Methotrexate—colon cancer	0.000119	0.00276	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.000119	0.0138	CbGpPWpGaD
Floxuridine—Angina pectoris—Capecitabine—colon cancer	0.000118	0.00274	CcSEcCtD
Floxuridine—Ill-defined disorder—Irinotecan—colon cancer	0.000117	0.00272	CcSEcCtD
Floxuridine—Anaemia—Irinotecan—colon cancer	0.000117	0.00271	CcSEcCtD
Floxuridine—Leukopenia—Vincristine—colon cancer	0.000116	0.00269	CcSEcCtD
Floxuridine—Pancytopenia—Capecitabine—colon cancer	0.000115	0.00267	CcSEcCtD
Floxuridine—Malaise—Irinotecan—colon cancer	0.000114	0.00264	CcSEcCtD
Floxuridine—Zidovudine—ABCB1—colon cancer	0.000113	0.138	CrCbGaD
Floxuridine—Leukopenia—Irinotecan—colon cancer	0.000113	0.00262	CcSEcCtD
Floxuridine—Anaemia—Fluorouracil—colon cancer	0.000112	0.00259	CcSEcCtD
Floxuridine—Photosensitivity reaction—Capecitabine—colon cancer	0.000111	0.00257	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—MLH3—colon cancer	0.00011	0.0128	CbGpPWpGaD
Floxuridine—Leukopenia—Fluorouracil—colon cancer	0.000108	0.00251	CcSEcCtD
Floxuridine—Lethargy—Methotrexate—colon cancer	0.000107	0.00247	CcSEcCtD
Floxuridine—Discomfort—Irinotecan—colon cancer	0.000106	0.00246	CcSEcCtD
Floxuridine—Anaphylactic shock—Vincristine—colon cancer	0.000106	0.00245	CcSEcCtD
Floxuridine—Stomatitis—Capecitabine—colon cancer	0.000105	0.00244	CcSEcCtD
Floxuridine—Infection—Vincristine—colon cancer	0.000105	0.00244	CcSEcCtD
Floxuridine—Confusional state—Irinotecan—colon cancer	0.000104	0.00241	CcSEcCtD
Floxuridine—Nervous system disorder—Vincristine—colon cancer	0.000104	0.00241	CcSEcCtD
Floxuridine—Thrombocytopenia—Vincristine—colon cancer	0.000104	0.0024	CcSEcCtD
Floxuridine—Anaphylactic shock—Irinotecan—colon cancer	0.000103	0.00239	CcSEcCtD
Floxuridine—Infection—Irinotecan—colon cancer	0.000102	0.00237	CcSEcCtD
Floxuridine—Epistaxis—Capecitabine—colon cancer	0.000102	0.00237	CcSEcCtD
Floxuridine—TYMP—Metabolism—CHST5—colon cancer	0.000102	0.0119	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ODC1—colon cancer	0.000102	0.0119	CbGpPWpGaD
Floxuridine—Discomfort—Fluorouracil—colon cancer	0.000102	0.00236	CcSEcCtD
Floxuridine—Nervous system disorder—Irinotecan—colon cancer	0.000101	0.00234	CcSEcCtD
Floxuridine—Agranulocytosis—Capecitabine—colon cancer	0.000101	0.00234	CcSEcCtD
Floxuridine—Thrombocytopenia—Irinotecan—colon cancer	0.000101	0.00234	CcSEcCtD
Floxuridine—Anorexia—Vincristine—colon cancer	0.000101	0.00234	CcSEcCtD
Floxuridine—Confusional state—Fluorouracil—colon cancer	9.96e-05	0.00231	CcSEcCtD
Floxuridine—Anaphylactic shock—Fluorouracil—colon cancer	9.88e-05	0.00229	CcSEcCtD
Floxuridine—TYMS—Fluoropyrimidine Activity—TP53—colon cancer	9.83e-05	0.0115	CbGpPWpGaD
Floxuridine—Anorexia—Irinotecan—colon cancer	9.83e-05	0.00228	CcSEcCtD
Floxuridine—Infection—Fluorouracil—colon cancer	9.81e-05	0.00227	CcSEcCtD
Floxuridine—Haemoglobin—Capecitabine—colon cancer	9.76e-05	0.00226	CcSEcCtD
Floxuridine—Haemorrhage—Capecitabine—colon cancer	9.71e-05	0.00225	CcSEcCtD
Floxuridine—Nervous system disorder—Fluorouracil—colon cancer	9.68e-05	0.00224	CcSEcCtD
Floxuridine—Thrombocytopenia—Fluorouracil—colon cancer	9.67e-05	0.00224	CcSEcCtD
Floxuridine—Pharyngitis—Capecitabine—colon cancer	9.64e-05	0.00223	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	9.49e-05	0.0111	CbGpPWpGaD
Floxuridine—Anorexia—Fluorouracil—colon cancer	9.41e-05	0.00218	CcSEcCtD
Floxuridine—Decreased appetite—Vincristine—colon cancer	9.2e-05	0.00213	CcSEcCtD
Floxuridine—Decreased appetite—Irinotecan—colon cancer	8.96e-05	0.00208	CcSEcCtD
Floxuridine—Gastrointestinal pain—Vincristine—colon cancer	8.66e-05	0.00201	CcSEcCtD
Floxuridine—TYMS—Metabolism—CA7—colon cancer	8.6e-05	0.01	CbGpPWpGaD
Floxuridine—Decreased appetite—Fluorouracil—colon cancer	8.58e-05	0.00199	CcSEcCtD
Floxuridine—Alopecia—Capecitabine—colon cancer	8.58e-05	0.00199	CcSEcCtD
Floxuridine—Pancytopenia—Methotrexate—colon cancer	8.58e-05	0.00199	CcSEcCtD
Floxuridine—Feeling abnormal—Irinotecan—colon cancer	8.5e-05	0.00197	CcSEcCtD
Floxuridine—Erythema—Capecitabine—colon cancer	8.46e-05	0.00196	CcSEcCtD
Floxuridine—Gastrointestinal pain—Irinotecan—colon cancer	8.43e-05	0.00195	CcSEcCtD
Floxuridine—Body temperature increased—Vincristine—colon cancer	8.37e-05	0.00194	CcSEcCtD
Floxuridine—Abdominal pain—Vincristine—colon cancer	8.37e-05	0.00194	CcSEcCtD
Floxuridine—Photosensitivity reaction—Methotrexate—colon cancer	8.25e-05	0.00191	CcSEcCtD
Floxuridine—Abdominal pain—Irinotecan—colon cancer	8.15e-05	0.00189	CcSEcCtD
Floxuridine—Body temperature increased—Irinotecan—colon cancer	8.15e-05	0.00189	CcSEcCtD
Floxuridine—Feeling abnormal—Fluorouracil—colon cancer	8.14e-05	0.00189	CcSEcCtD
Floxuridine—Muscle spasms—Capecitabine—colon cancer	8.13e-05	0.00188	CcSEcCtD
Floxuridine—Stomatitis—Methotrexate—colon cancer	7.85e-05	0.00182	CcSEcCtD
Floxuridine—Ill-defined disorder—Capecitabine—colon cancer	7.85e-05	0.00182	CcSEcCtD
Floxuridine—Anaemia—Capecitabine—colon cancer	7.82e-05	0.00181	CcSEcCtD
Floxuridine—Body temperature increased—Fluorouracil—colon cancer	7.81e-05	0.00181	CcSEcCtD
Floxuridine—Hypersensitivity—Vincristine—colon cancer	7.8e-05	0.00181	CcSEcCtD
Floxuridine—TYMS—E2F transcription factor network—CDKN1A—colon cancer	7.65e-05	0.00891	CbGpPWpGaD
Floxuridine—Malaise—Capecitabine—colon cancer	7.63e-05	0.00177	CcSEcCtD
Floxuridine—Epistaxis—Methotrexate—colon cancer	7.6e-05	0.00176	CcSEcCtD
Floxuridine—Hypersensitivity—Irinotecan—colon cancer	7.6e-05	0.00176	CcSEcCtD
Floxuridine—Asthenia—Vincristine—colon cancer	7.6e-05	0.00176	CcSEcCtD
Floxuridine—Leukopenia—Capecitabine—colon cancer	7.57e-05	0.00175	CcSEcCtD
Floxuridine—Agranulocytosis—Methotrexate—colon cancer	7.52e-05	0.00174	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	7.41e-05	0.00863	CbGpPWpGaD
Floxuridine—Asthenia—Irinotecan—colon cancer	7.4e-05	0.00171	CcSEcCtD
Floxuridine—TYMS—E2F transcription factor network—EP300—colon cancer	7.28e-05	0.00848	CbGpPWpGaD
Floxuridine—Hypersensitivity—Fluorouracil—colon cancer	7.28e-05	0.00169	CcSEcCtD
Floxuridine—Haemoglobin—Methotrexate—colon cancer	7.27e-05	0.00168	CcSEcCtD
Floxuridine—Diarrhoea—Vincristine—colon cancer	7.24e-05	0.00168	CcSEcCtD
Floxuridine—Haemorrhage—Methotrexate—colon cancer	7.23e-05	0.00168	CcSEcCtD
Floxuridine—Pharyngitis—Methotrexate—colon cancer	7.18e-05	0.00166	CcSEcCtD
Floxuridine—Discomfort—Capecitabine—colon cancer	7.11e-05	0.00165	CcSEcCtD
Floxuridine—Diarrhoea—Irinotecan—colon cancer	7.05e-05	0.00164	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	7.01e-05	0.00816	CbGpPWpGaD
Floxuridine—Confusional state—Capecitabine—colon cancer	6.96e-05	0.00161	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—CCND1—colon cancer	6.87e-05	0.00801	CbGpPWpGaD
Floxuridine—Infection—Capecitabine—colon cancer	6.86e-05	0.00159	CcSEcCtD
Floxuridine—Nervous system disorder—Capecitabine—colon cancer	6.77e-05	0.00157	CcSEcCtD
Floxuridine—Diarrhoea—Fluorouracil—colon cancer	6.76e-05	0.00157	CcSEcCtD
Floxuridine—Thrombocytopenia—Capecitabine—colon cancer	6.76e-05	0.00157	CcSEcCtD
Floxuridine—Vomiting—Vincristine—colon cancer	6.73e-05	0.00156	CcSEcCtD
Floxuridine—Rash—Vincristine—colon cancer	6.68e-05	0.00155	CcSEcCtD
Floxuridine—Dermatitis—Vincristine—colon cancer	6.67e-05	0.00155	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1A—colon cancer	6.65e-05	0.00774	CbGpPWpGaD
Floxuridine—Headache—Vincristine—colon cancer	6.63e-05	0.00154	CcSEcCtD
Floxuridine—Anorexia—Capecitabine—colon cancer	6.58e-05	0.00152	CcSEcCtD
Floxuridine—Vomiting—Irinotecan—colon cancer	6.56e-05	0.00152	CcSEcCtD
Floxuridine—Rash—Irinotecan—colon cancer	6.5e-05	0.00151	CcSEcCtD
Floxuridine—Dermatitis—Irinotecan—colon cancer	6.5e-05	0.00151	CcSEcCtD
Floxuridine—Headache—Irinotecan—colon cancer	6.46e-05	0.0015	CcSEcCtD
Floxuridine—Alopecia—Methotrexate—colon cancer	6.39e-05	0.00148	CcSEcCtD
Floxuridine—TYMS—E2F transcription factor network—MYC—colon cancer	6.34e-05	0.00739	CbGpPWpGaD
Floxuridine—Erythema—Methotrexate—colon cancer	6.29e-05	0.00146	CcSEcCtD
Floxuridine—Nausea—Vincristine—colon cancer	6.29e-05	0.00146	CcSEcCtD
Floxuridine—Vomiting—Fluorouracil—colon cancer	6.28e-05	0.00146	CcSEcCtD
Floxuridine—Rash—Fluorouracil—colon cancer	6.23e-05	0.00144	CcSEcCtD
Floxuridine—Dermatitis—Fluorouracil—colon cancer	6.22e-05	0.00144	CcSEcCtD
Floxuridine—Headache—Fluorouracil—colon cancer	6.19e-05	0.00143	CcSEcCtD
Floxuridine—Nausea—Irinotecan—colon cancer	6.12e-05	0.00142	CcSEcCtD
Floxuridine—Decreased appetite—Capecitabine—colon cancer	6e-05	0.00139	CcSEcCtD
Floxuridine—Nausea—Fluorouracil—colon cancer	5.87e-05	0.00136	CcSEcCtD
Floxuridine—Ill-defined disorder—Methotrexate—colon cancer	5.84e-05	0.00135	CcSEcCtD
Floxuridine—Anaemia—Methotrexate—colon cancer	5.82e-05	0.00135	CcSEcCtD
Floxuridine—Feeling abnormal—Capecitabine—colon cancer	5.69e-05	0.00132	CcSEcCtD
Floxuridine—Malaise—Methotrexate—colon cancer	5.68e-05	0.00132	CcSEcCtD
Floxuridine—Gastrointestinal pain—Capecitabine—colon cancer	5.64e-05	0.00131	CcSEcCtD
Floxuridine—Leukopenia—Methotrexate—colon cancer	5.63e-05	0.00131	CcSEcCtD
Floxuridine—TYMS—G1/S Transition—CDKN1A—colon cancer	5.55e-05	0.00647	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—MYC—colon cancer	5.51e-05	0.00642	CbGpPWpGaD
Floxuridine—Body temperature increased—Capecitabine—colon cancer	5.46e-05	0.00126	CcSEcCtD
Floxuridine—Abdominal pain—Capecitabine—colon cancer	5.46e-05	0.00126	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—APC—colon cancer	5.34e-05	0.00622	CbGpPWpGaD
Floxuridine—Discomfort—Methotrexate—colon cancer	5.29e-05	0.00123	CcSEcCtD
Floxuridine—TYMS—Metabolism—ODC1—colon cancer	5.21e-05	0.00607	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CHST5—colon cancer	5.21e-05	0.00607	CbGpPWpGaD
Floxuridine—Confusional state—Methotrexate—colon cancer	5.18e-05	0.0012	CcSEcCtD
Floxuridine—Anaphylactic shock—Methotrexate—colon cancer	5.14e-05	0.00119	CcSEcCtD
Floxuridine—Infection—Methotrexate—colon cancer	5.1e-05	0.00118	CcSEcCtD
Floxuridine—Hypersensitivity—Capecitabine—colon cancer	5.08e-05	0.00118	CcSEcCtD
Floxuridine—Nervous system disorder—Methotrexate—colon cancer	5.04e-05	0.00117	CcSEcCtD
Floxuridine—Thrombocytopenia—Methotrexate—colon cancer	5.03e-05	0.00117	CcSEcCtD
Floxuridine—Asthenia—Capecitabine—colon cancer	4.95e-05	0.00115	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—PPARG—colon cancer	4.95e-05	0.00576	CbGpPWpGaD
Floxuridine—Anorexia—Methotrexate—colon cancer	4.9e-05	0.00114	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CCND1—colon cancer	4.83e-05	0.00563	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—MLH1—colon cancer	4.83e-05	0.00563	CbGpPWpGaD
Floxuridine—Diarrhoea—Capecitabine—colon cancer	4.72e-05	0.00109	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDKN1A—colon cancer	4.68e-05	0.00545	CbGpPWpGaD
Floxuridine—TYMS—G1/S Transition—MYC—colon cancer	4.6e-05	0.00536	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—BUB1B—colon cancer	4.59e-05	0.00535	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—TP53—colon cancer	4.53e-05	0.00527	CbGpPWpGaD
Floxuridine—Decreased appetite—Methotrexate—colon cancer	4.47e-05	0.00104	CcSEcCtD
Floxuridine—Vomiting—Capecitabine—colon cancer	4.39e-05	0.00102	CcSEcCtD
Floxuridine—Rash—Capecitabine—colon cancer	4.35e-05	0.00101	CcSEcCtD
Floxuridine—Dermatitis—Capecitabine—colon cancer	4.35e-05	0.00101	CcSEcCtD
Floxuridine—Headache—Capecitabine—colon cancer	4.32e-05	0.001	CcSEcCtD
Floxuridine—Feeling abnormal—Methotrexate—colon cancer	4.23e-05	0.000981	CcSEcCtD
Floxuridine—Gastrointestinal pain—Methotrexate—colon cancer	4.2e-05	0.000974	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—BUB1B—colon cancer	4.11e-05	0.00479	CbGpPWpGaD
Floxuridine—Nausea—Capecitabine—colon cancer	4.1e-05	0.00095	CcSEcCtD
Floxuridine—Body temperature increased—Methotrexate—colon cancer	4.06e-05	0.000941	CcSEcCtD
Floxuridine—Abdominal pain—Methotrexate—colon cancer	4.06e-05	0.000941	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	4.05e-05	0.00472	CbGpPWpGaD
Floxuridine—TYMS—Mitotic G1-G1/S phases—MYC—colon cancer	3.88e-05	0.00452	CbGpPWpGaD
Floxuridine—Hypersensitivity—Methotrexate—colon cancer	3.78e-05	0.000877	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	3.76e-05	0.00438	CbGpPWpGaD
Floxuridine—Asthenia—Methotrexate—colon cancer	3.69e-05	0.000854	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	3.66e-05	0.00427	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	3.63e-05	0.00423	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	3.54e-05	0.00413	CbGpPWpGaD
Floxuridine—Diarrhoea—Methotrexate—colon cancer	3.51e-05	0.000815	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	3.37e-05	0.00393	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	3.28e-05	0.00382	CbGpPWpGaD
Floxuridine—Vomiting—Methotrexate—colon cancer	3.27e-05	0.000757	CcSEcCtD
Floxuridine—Rash—Methotrexate—colon cancer	3.24e-05	0.000751	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—EP300—colon cancer	3.24e-05	0.00377	CbGpPWpGaD
Floxuridine—Dermatitis—Methotrexate—colon cancer	3.24e-05	0.00075	CcSEcCtD
Floxuridine—Headache—Methotrexate—colon cancer	3.22e-05	0.000746	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	3.19e-05	0.00372	CbGpPWpGaD
Floxuridine—Nausea—Methotrexate—colon cancer	3.05e-05	0.000707	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	2.94e-05	0.00342	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	2.93e-05	0.00341	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	2.87e-05	0.00335	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	2.71e-05	0.00316	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ABCB1—colon cancer	2.69e-05	0.00314	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—TYMS—colon cancer	2.64e-05	0.00308	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	2.49e-05	0.00291	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	2.41e-05	0.00281	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—TP53—colon cancer	2.32e-05	0.0027	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	2.04e-05	0.00237	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PPARG—colon cancer	1.87e-05	0.00218	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CCND1—colon cancer	1.77e-05	0.00207	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDKN1A—colon cancer	1.72e-05	0.002	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—EP300—colon cancer	1.63e-05	0.0019	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CCND1—colon cancer	1.59e-05	0.00185	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CDKN1A—colon cancer	1.53e-05	0.00179	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PTGS2—colon cancer	1.47e-05	0.00172	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—EP300—colon cancer	1.46e-05	0.0017	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—MYC—colon cancer	1.42e-05	0.00166	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ABCB1—colon cancer	1.38e-05	0.0016	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—MYC—colon cancer	1.27e-05	0.00148	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—EP300—colon cancer	1.23e-05	0.00143	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—TP53—colon cancer	1.04e-05	0.00122	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PPARG—colon cancer	9.58e-06	0.00112	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PIK3CA—colon cancer	9.07e-06	0.00106	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PTGS2—colon cancer	7.54e-06	0.000878	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—AKT1—colon cancer	7.41e-06	0.000863	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—EP300—colon cancer	6.27e-06	0.000731	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PIK3CA—colon cancer	4.64e-06	0.00054	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—AKT1—colon cancer	3.79e-06	0.000441	CbGpPWpGaD
